Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Recipharm

www.recipharm.com

Box 603
Stockholm
101 32
Sweden

+ 46 8 602 52 00

Activities

Manufacturing | Ingredients | Drug Delivery | Research & Development | Pharmaceutical

Related Companies

  • Lonza
  • Hermes Pharma GmbH
  • GEA Pharma and Healthcare
  • Titan Enterprises
  • Actylis – The Partner of Choice
  • ProtaGene
  • Qualicaps
  • Austar
  • Asynt
  • LB Bohle
  • Vetter Pharma International
  • Starlab
  • Gerresheimer
  • Romaco Holding GmbH
  • Vectorbuilder Inc
  • Innopharma Technology
  • Butterworth Laboratories
  • C-squared Pharma
  • DWK Life Sciences
  • Indena

Related Content

Partnership speeds the development of pressurised metered dose inhalers
Partnership speeds the development of pressurised metered dose inhalers
Recipharm’s analytical lab brings testing capabilities to global markets
Recipharm’s analytical lab brings testing capabilities to global markets
Arranta Bio signs contract for continuous mRNA manufacturing tech
Arranta Bio signs contract for continuous mRNA manufacturing tech
Recipharm appoints Joaquim Mascaro as Chief Financial Officer
Recipharm appoints Joaquim Mascaro as Chief Financial Officer
BES completes $4.8m refurb for Recipharm
BES completes $4.8m refurb for Recipharm
Recipharm extends commercial manufacturing for RedHill’s drug
Recipharm extends commercial manufacturing for RedHill’s drug
What does 2023 hold for oral solid dosage forms?
What does 2023 hold for oral solid dosage forms?
Recipharm bolsters blow-fill-seal capabilities with Lab+
Recipharm bolsters blow-fill-seal capabilities with Lab+
Managing the next pandemic: how prepared are we?
Managing the next pandemic: how prepared are we?
Transpire Bio announces agreement with Recipharm for the development of an inhaled medicine
Transpire Bio announces agreement with Recipharm for the development of an inhaled medicine
Recipharm expands services for pMDI propellants
Recipharm expands services for pMDI propellants
Recipharm completes two acquisitions
Recipharm completes two acquisitions
Recipharm invests in high-speed filling line for aseptics
Recipharm invests in high-speed filling line for aseptics
Recipharm expands ATMPs capabilities with CDMO acquisition
Recipharm expands ATMPs capabilities with CDMO acquisition
Recipharm acquires Portuguese CDMO for biologics capabilities
Recipharm acquires Portuguese CDMO for biologics capabilities
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company